FUSEN PHARM (01652) FY25 loss reduced to RMB11.78M X
01/04/2026 18:40
(Infocast News)      Results of Fusen Pharmaceutical Company Limited (01652) for the fiscal year ended 31 December 2025:

Net loss: RMB11.784M (RMB188.783M net loss for the same period last year) 
Basic LPS: RMB0.0159
Dividend per share proposed: (Nil)

(WH)

(C) Copyright by Infocast Ltd. All Rights Reserved.

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.